Alert detail
FDA Approval: TAUKLARIFY (FLORQUINITAU F18) — Type 1 - New Molecular Entity
Policy ID: FDA-NDA220496Specialty: RadiologyAdded: 8/19/2026Effective: August 13, 2026billing update
What changed
New tau PET agent TAUKLARIFY approved; watch for new J-code.
Who’s affected: Radiology billing teams · Effective: August 13, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.